
Sign up to save your podcasts
Or


Tobias Derfuss discusses his rapid review on advances in oral immunomodulating therapies in relapsing multiple sclerosis.
By The Lancet NeurologyTobias Derfuss discusses his rapid review on advances in oral immunomodulating therapies in relapsing multiple sclerosis.

43,686 Listeners

300 Listeners

533 Listeners

50 Listeners

112,584 Listeners

89 Listeners

514 Listeners

179 Listeners

58 Listeners

79 Listeners

0 Listeners